Dr. Iwata on Final OS Results From the Phase 3 IMpassion130 Trial in TNBC
November 20th 2020
Hiroji Iwata, MD, PhD, vice director and chief of Breast Oncology at Aichi Cancer Center Hospital, discusses final overall survival results from the phase 3 IMpassion130 trial in triple-negative breast cancer.